R&D Systems™ Recombinant Human LSECtin/CLEC4G Protein, CF

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Supplier:  R&D Systems™ 2947CL050

Catalog No. 2947CL050

Description

Measured by its ability to bind Jurkat human acute T cell leukemia cells in a flow cytometry assay. A 2-8 fold increase in fluorescence intensity can be observed when Jurkat cells are stained with 10 μg/tube rhLSECtin/his and mouse anti-polyHistidine-PE as compared to cells stained with Mouse Anti-polyHistidine PE-conjugated Monoclonal Antibody (Catalog # IC050P ). Optimal dilutions should be determined by each laboratory for each application.

Specifications

• Accession Number: NP_940894
• Formulation: Lyophilized from a 0.2 µm filtered solution in Tris-Citrate and NaCl.
• Molecular Weight (g/mol): M.W. (Observed): 37 kDa, reducing conditions; M.W. (theoretical): 27.8 kDa
• Purity: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Source: Mouse myeloma cell line, NS0-derived human LSECtin/CLEC4G protein Ser54-Cys293, with an N-terminal 9-His tag
• Endotoxin Concentration: <0.10 EU / 1 µg of the protein by the LAL method.
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 100 µg/mL in sterile PBS.

• For Use With (Application): Binding Activity
• Gene ID (Entrez): 339390
• Name: LSECtin/CLEC4G
• Quantity: 50 µg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Gene Symbol: CLEC4G
• Recombinant: Yes
• Protein: LSECtin/CLEC4G